Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

Tumor Mutational Burden in SCLC: A Valuable Immunotherapy Biomarker?

By Beacon Medical Interchange FEATURING Jack West

0 views

November 2, 2018

Dr. Jack West reviews new findings highlighting the utility of using the biomarker tumor mutation ...
read more ↘ burden (TMB) to predict which patients with small cell lung cancer (SCLC) will benefit from nivolumab or the combination of nivolumab with ipilimumab.
↖ read less

Comments 0